News Release

2010.10.05

FY02/2011 Q2 Results Earnings Release Presentation

2010.10.01

Noven Pharmaceuticals, Inc. press release : Noven completes acquisition of Daytrana® methylphenidate transdermal system (CII) from Shire

2010.08.27

Conduct ofAdditional Clinical Study of KW-2246, a Cancer Pain Drug

2010.08.11

Noven Pharmaceuticals, Inc. press release : Noven to acquire Daytrana® methylphenidate transdermal system from Shire

2010.06.30

FY02/2011 Q1 Results Earnings Release Presentation

2010.06.14

Financial Support to SAGA Heavy Ion Medical Accelerator in Tosu Project

2010.06.11

Announcement of Listing of “FENTOS® TAPE,” a transdermal, long-acting cancer pain relief patch, on the NHI Drug Price Standard

2010.05.26

Notice of Application for Delisting of Stock on Osaka Stock Exchange

2010.05.26

Notice of Personnel Changes

2010.04.23

Results of Phase III Clinical Trial of HKT-500 in the USA

2010.04.16

Hisamitsu Pharmaceutical Announces Marketing Approval of FENTOS® TAPE (Development Code: HFT-290), Transdermal, Long-Acting Cancer Pain Relief Patch

2010.04.08

FY02/2010 Q4 Results Earnings Release Presentation

2010.03.25

Hisamitsu Announces U.S. Launch of its “Fentanyl Transdermal System” for the Management of Chronic Pain

2010.03.24

Revision of Earnings Forecast

2010.02.25

Application Filed for Cancer Pain Drug (KW-2246)

2010.02.01

Kyowa Hakko Kirin and Hisamitsu entered into a Joint Distribution Agreement on Cancer Pain Drug (Development Code: KW-2246)

2010.01.08

FY02/2010 Q3 Results Earnings Release Presentation